Predicting the Risk of Secondary Malignancies Associated With Pelvic Nodal Irradiation in the Treatment of Prostate Cancer

被引：0
|
作者：
Jain, A. K. [1 ]
Shuryak, I. [2 ]
Ng, J. [1 ]
Chao, K. S. [1 ]
Brenner, D. J. [2 ]
Deutsch, I. [1 ]
机构：
[1] Columbia Univ, Med Ctr, Dept Radiat Oncol, New York, NY USA
[2] Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 84卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2012.07.982
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S372 / S372
页数：1
相关论文
共 50 条
  • [31] Toxicity of pelvic nodal radiation for localized prostate cancer
    Haque, Waqar
    Butler, E. Brian
    Teh, Bin S.
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [32] Simultaneous-integrated boost (SIB) IMRT for treatment of indermediate-risk prostate cancer with nodal irradiation
    Dogan, N.
    Wu, Y.
    Hagan, M. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S661 - S661
  • [33] Predicting the risk of secondary malignancies associated with stereotactic body radiation therapy.
    Horowitz, David Paul
    Ng, John
    Shuryak, Igor
    Chao, K. S. Clifford
    Brenner, David J.
    Cheng, Simon
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [34] Multiple primary malignancies in patients with prostate cancer: increased risk of secondary malignancies after radiotherapy
    Kaoru Okajima
    Kazuki Ishikawa
    Tomohiro Matsuura
    Hitoshi Tatebe
    Kazuhisa Fujiwara
    Keiji Hiroi
    Hirokazu Hasegawa
    Yasumasa Nishimura
    International Journal of Clinical Oncology, 2013, 18 : 1078 - 1084
  • [35] Elective Pelvic Nodal Irradiation With a Simultaneous Hypofractionated Integrated Prostate Boost for Localised Prostate Cancer: Ready for Prime Time?
    Cheung, P.
    Niazi, T.
    Faria, S.
    Loblaw, A.
    CLINICAL ONCOLOGY, 2020, 32 (03) : 181 - 188
  • [36] WHOLE-PELVIC NODAL IRRADIATION WITH HYPOFRACTIONATED SIMULTANEOUS INTEGRATED BOOST FOR HIGH-RISK PROSTATE CANCER: OUTCOME AND LATE TOXICITY
    Magli, Alessandro
    Moretti, Eugenia
    Tullio, Annarita
    Ceschia, Tino
    Chiaulon, Germana
    Parisi, Giuseppe
    Signor, Marco Andrea
    Crespi, Margherita
    Foti, Claudio
    De Giorgi, Gioacchino
    Sacco, Cosimo Stanislao
    ANTICANCER RESEARCH, 2017, 37 (04) : 2070 - 2071
  • [37] Multiple primary malignancies in patients with prostate cancer: increased risk of secondary malignancies after radiotherapy
    Okajima, Kaoru
    Ishikawa, Kazuki
    Matsuura, Tomohiro
    Tatebe, Hitoshi
    Fujiwara, Kazuhisa
    Hiroi, Keiji
    Hasegawa, Hirokazu
    Nishimura, Yasumasa
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (06) : 1078 - 1084
  • [38] Watchful waiting and predicting factors for secondary treatment in prostate cancer
    Wu, HY
    Sun, L
    Moul, JW
    Wu, HY
    McLeod, D
    Amling, C
    Lance, R
    Kusuda, L
    Donahue, T
    Foley, J
    Chung, A
    Sexton, W
    Soderdahl, D
    JOURNAL OF UROLOGY, 2003, 169 (04) : 493 - 493
  • [39] Patient-Reported Rectal QOL with Pelvic Nodal Irradiation ± Involved Pelvic Nodal Boost to 75 Gy EQD2 in Men with Prostate Cancer
    Roach, E.
    Hutten, R.
    Johnson, S. B.
    Tward, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E244 - E244
  • [40] Pelvic Nodal Dosing With Registration to the Prostate: Implications for High-Risk Prostate Cancer Patients Receiving SBRT
    Kishan, A. U.
    King, C. R.
    Jani, S.
    Steinberg, M. L.
    Lamb, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S410 - S410
12345